Provided by Tiger Trade Technology Pte. Ltd.

Relay Therapeutics

16.93
-1.0250-5.71%
Volume:868.16K
Turnover:14.96M
Market Cap:3.71B
PE:-10.81
High:17.97
Open:17.71
Low:16.87
Close:17.95
52wk High:21.27
52wk Low:5.83
Shares:219.14M
Float Shares:145.00M
Volume Ratio:0.69
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5651
EPS(LYR):-1.6113
ROE:-36.77%
ROA:-22.88%
PB:4.17
PE(LYR):-10.50

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: American Well (AMWL) and Relay Therapeutics (RLAY)

TIPRANKS
·
May 06

Relay Therapeutics Q1 EPS $(0.41) Misses $(0.37) Estimate, Sales $3.000M Beat $2.560M Estimate

Benzinga Earnings
·
May 06

BRIEF-Relay Therapeutics Q1 Net Income USD -73.291 Million Vs. IBES Estimate USD -65 Million

Reuters
·
May 06

Relay Therapeutics Q1 Operating Expenses USD 81.59 Million

THOMSON REUTERS
·
May 06

Relay Therapeutics Q1 EPS USD -0.41

THOMSON REUTERS
·
May 06

Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates

GlobeNewswire
·
May 06

Relay Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
May 02

Top Relay Therapeutics Executives Quietly Unload Shares in Coordinated Move

TIPRANKS
·
May 01

Relay Therapeutics to report first-quarter results after market close

Reuters
·
Apr 30

Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026

GlobeNewswire
·
Apr 30

Relay Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $25 From $19

THOMSON REUTERS
·
Apr 29

Relay Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Apr 28

Oppenheimer Adjusts Relay Therapeutics Price Target to $18 From $14, Maintains Outperform Rating

MT Newswires Live
·
Apr 28

Relay Therapeutics : Oppenheimer Raises Target Price to $18 From $14

THOMSON REUTERS
·
Apr 28

Relay Therapeutics price target raised to $21 from $17 at Wells Fargo

TIPRANKS
·
Apr 28

Relay Therapeutics price target raised to $19 from $17 at Citizens

TIPRANKS
·
Apr 28

Barclays Reaffirms Their Buy Rating on Relay Therapeutics (RLAY)

TIPRANKS
·
Apr 28

Relay Therapeutics Inc : Raymond James Raises Target Price to $23 From $19

THOMSON REUTERS
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Cormedix (CRMD) and Relay Therapeutics (RLAY)

TIPRANKS
·
Apr 28

Relay Therapeutics advances zovegalisib combo in breast cancer

TIPRANKS
·
Apr 27